24 Phase III study of gemcitabine (Gemzar®) versus best supportive care (BSC) in advanced non-small cell lung cancer (NSCLC)
- 1 August 1997
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: